About this Journal Submit a Manuscript Table of Contents
Journal of Nanomaterials
Volume 2011 (2011), Article ID 408675, 10 pages
http://dx.doi.org/10.1155/2011/408675
Review Article

Emerging Technologies of Polymeric Nanoparticles in Cancer Drug Delivery

Department of Chemical and Biological Engineering, Drexel University, 3141 Chestnut Street, Philadelphia, PA 19104, USA

Received 2 June 2010; Accepted 2 August 2010

Academic Editor: Lu Sun

Copyright © 2011 Erik Brewer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. K. Working and A. D. Dayan, “Pharmacological-toxicological Expert Report. Caelyx. (Stealth liposomal doxorubicin HCl),” Human and Experimental Toxicology, vol. 15, no. 9, pp. 751–785, 1996. View at Scopus
  2. T. L. ten Hagen, A. L. Seynhaeve, S. T. van Tiel, D. J. Ruiter, and A. M. Eggermont, “Pegylated liposomal tumor necrosis factor-α results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil) in soft tissue sarcoma-bearing rats,” International Journal of Cancer, vol. 97, no. 1, pp. 115–120, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. A. Gabizon, H. Shmeeda, and Y. Barenholz, “Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies,” Clinical Pharmacokinetics, vol. 42, no. 5, pp. 419–436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. A. A. Gabizon, “Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes,” Cancer Research, vol. 52, no. 4, pp. 891–896, 1992. View at Scopus
  5. D. W. Northfelt, F. J. Martin, P. Working et al., “Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma,” Journal of Clinical Pharmacology, vol. 36, no. 1, pp. 55–63, 1996. View at Scopus
  6. T. M. Allen and P. R. Cullis, “Drug delivery systems: entering the mainstream,” Science, vol. 303, no. 5665, pp. 1818–1822, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. M. Yokoyama, T. Okano, Y. Sakurai, H. Ekimoto, C. Shibazaki, and K. Kataoka, “Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood,” Cancer Research, vol. 51, no. 12, pp. 3229–3236, 1991. View at Scopus
  8. M. L. Hans and A. M. Lowman, “Biodegradable nanoparticles for drug delivery and targeting,” Current Opinion in Solid State and Materials Science, vol. 6, no. 4, pp. 319–327, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Zhang, A. F. Radovic-Moreno, F. Alexis et al., “Co-delivery of hydrophobic and hydrophilic drugsfrom nanoparticle-aptamer bioconjugates,” ChemMedChem, vol. 2, no. 9, pp. 1268–1271, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. R. Herrero-Vanrell and M. F. Refojo, “Biodegradable microspheres for vitreoretinal drug delivery,” Advanced Drug Delivery Reviews, vol. 52, no. 1, pp. 5–16, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. D. H. Lewis, “Controlled release of bioactive agents from lactide/glycolide polymers,” in Biodegradable Polymers as Drug Delivery Devices, M. Chasin and R. Langer, Eds., pp. 1–41, Marcel Dekker, New York, NY, USA, 1990.
  12. R. Langer and J. P. Vacanti, “Tissue engineering,” Science, vol. 260, no. 5110, pp. 920–926, 1993. View at Scopus
  13. E. Chiellini and R. Solaro, “Biodegradable polymeric materials,” Advanced Materials, vol. 8, no. 4, pp. 305–313, 1996. View at Scopus
  14. B. Jeong, Y. H. Bae, D. S. Lee, and S. W. Kim, “Biodegradable block copolymers as injectable drug-delivery systems,” Nature, vol. 388, no. 6645, pp. 860–862, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. K. Okada, H. Kawaide, T. Kuzuyama, H. Seto, I. S. Curtis, and Y. Kamiya, “Antisense and chemical suppression of the nonmevalonate pathway affects ent-kaurene biosynthesis in Arabidopsis,” Planta, vol. 215, no. 2, pp. 339–344, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. A. Lavasanifar, J. Samuel, and G. S. Kwon, “Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery,” Advanced Drug Delivery Reviews, vol. 54, no. 2, pp. 169–190, 2002. View at Publisher · View at Google Scholar
  17. M. Yokoyama, M. Miyauchi, N. Yamada et al., “Characterization and anticancer activity of the micelle-forming polymeric anticancer drug Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer,” Cancer Research, vol. 50, no. 6, pp. 1693–1700, 1990.
  18. D. D. Lasic, J. J. Vallner, and P. K. Working, “Sterically stabilized liposomes in cancer therapy and gene delivery,” Current Opinion in Molecular Therapeutics, vol. 1, no. 2, pp. 177–185, 1999.
  19. T. M. Allen, M. S. Newman, M. C. Woodle, E. Mayhew, and P. S. Uster, “Pharmacokinetics and anti-tumor activity of vincristine encapsulated in sterically stabilized liposomes,” International Journal of Cancer, vol. 62, no. 2, pp. 199–204, 1995. View at Publisher · View at Google Scholar
  20. R. Gref, M. Lück, P. Quellec et al., “‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption,” Colloids and Surfaces B, vol. 18, no. 3-4, pp. 301–313, 2000. View at Publisher · View at Google Scholar
  21. R. Gref, Y. Minamitake, M. T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer, “Biodegradable long-circulating polymeric nanospheres,” Science, vol. 263, no. 5153, pp. 1600–1603, 1994.
  22. M. Tobío, R. Gref, A. Sánchez, R. Langer, and M. J. Alonso, “Stealth PLA-PEG nanoparticles as protein carriers for nasal administration,” Pharmaceutical Research, vol. 15, no. 2, pp. 270–275, 1998. View at Publisher · View at Google Scholar
  23. D. E. Owens III and N. A. Peppas, “Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles,” International Journal of Pharmaceutics, vol. 307, no. 1, pp. 93–102, 2006. View at Publisher · View at Google Scholar · View at PubMed
  24. X. Zhang, Y. Li, X. Chen et al., “Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugate,” Biomaterials, vol. 26, no. 14, pp. 2121–2128, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori, “Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review,” Journal of Controlled Release, vol. 65, no. 1-2, pp. 271–284, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Duncan, M. J. Vicent, F. Greco, and R. I. Nicholson, “Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer,” Endocrine-Related Cancer, vol. 12, supplement 1, pp. S189–S199, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. L. Li, T. L. M. ten Hagen, D. Schipper et al., “Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia,” Journal of Controlled Release, vol. 143, no. 2, pp. 274–279, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. P. J. Cagnoni, “Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients,” Journal of Antimicrobial Chemotherapy, vol. 49, supplement 1, pp. 81–86, 2002. View at Scopus
  29. I. Judson, J. A. Radford, M. Harris et al., “Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group,” European Journal of Cancer, vol. 37, no. 7, pp. 870–877, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. T. J. Walsh, R. W. Finberg, C. Arndt et al., “Liposomal amphotericin b for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group,” New England Journal of Medicine, vol. 340, no. 10, pp. 764–771, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. J. Y. Lu, D. A. Lowe, M. D. Kennedy, and P. S. Low, “Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug,” Journal of Drug Targeting, vol. 7, no. 1, pp. 43–53, 1999. View at Scopus
  32. Y. Lu and P. S. Low, “Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors,” Cancer Immunology, Immunotherapy, vol. 51, no. 3, pp. 153–162, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. H. S. Yoo and T. G. Park, “Folate receptor targeted biodegradable polymeric doxorubicin micelles,” Journal of Controlled Release, vol. 96, no. 2, pp. 273–283, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. J. Cummings and C. S. McArdle, “Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug,” British Journal of Cancer, vol. 53, no. 6, pp. 835–838, 1986. View at Scopus
  35. D. Goren, A. T. Horowitz, D. Tzemach, M. Tarshish, S. Zalipsky, and A. Gabizon, “Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump,” Clinical Cancer Research, vol. 6, no. 5, pp. 1949–1957, 2000. View at Scopus
  36. S. D. Weitman, A. G. Weinberg, L. R. Coney, V. R. Zurawski, D. S. Jennings, and B. A. Kamen, “Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis,” Cancer Research, vol. 52, no. 23, pp. 6708–6711, 1992. View at Scopus
  37. J. A. Reddy and P. S. Low, “Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation,” Journal of Controlled Release, vol. 64, no. 1–3, pp. 27–37, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Wang, R. J. Lee, G. Cauchon, D. G. Gorenstein, and P. S. Low, “Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 8, pp. 3318–3322, 1995. View at Scopus
  39. H. S. Yoo, J. E. Oh, K. H. Lee, and T. G. Park, “Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release,” Pharmaceutical Research, vol. 16, no. 7, pp. 1114–1118, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. H. S. Yoo and T. G. Park, “Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer,” Journal of Controlled Release, vol. 70, no. 1-2, pp. 63–70, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. G. S. Kwon and K. Kataoka, “Block copolymer micelles as long-circulating drug vehicles,” Advanced Drug Delivery Reviews, vol. 16, no. 2-3, pp. 295–309, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Kwon, M. Naito, M. Yokoyama, T. Okano, Y. Sakurai, and K. Kataoka, “Block copolymer micelles for drug delivery: loading and release of doxorubicin,” Journal of Controlled Release, vol. 48, no. 2-3, pp. 195–201, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Kwon, S. Suwa, M. Yokoyama, T. Okano, Y. Sakurai, and K. Kataoka, “Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates,” Journal of Controlled Release, vol. 29, no. 1-2, pp. 17–23, 1994. View at Scopus
  44. G. S. Kwon, M. Yokoyama, T. Okano, Y. Sakurai, and K. Kataoka, “Biodistribution of micelle-forming polymer-drug conjugates,” Pharmaceutical Research, vol. 10, no. 7, pp. 970–974, 1993. View at Publisher · View at Google Scholar · View at Scopus
  45. Y.-P. Li, Y.-Y. Pei, X.-Y. Zhang et al., “PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats,” Journal of Controlled Release, vol. 71, no. 2, pp. 203–211, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. G. F. Joyce, “Amplification, mutation and selection of catalytic RNA,” Gene, vol. 82, no. 1, pp. 83–87, 1989. View at Scopus
  47. S. D. Jayasena, “Aptamers: an emerging class of molecules that rival antibodies in diagnostics,” Clinical Chemistry, vol. 45, no. 9, pp. 1628–1650, 1999. View at Scopus
  48. S. Tombelli, M. Minunni, E. Luzi, and M. Mascini, “Aptamer-based biosensors for the detection of HIV-1 Tat protein,” Bioelectrochemistry, vol. 67, no. 2, pp. 135–141, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. T. Mairal, V. C. Özalp, P. Lozano Sánchez, M. Mir, I. Katakis, and C. K. O'Sullivan, “Aptamers: molecular tools for analytical applications,” Analytical and Bioanalytical Chemistry, vol. 390, no. 4, pp. 989–1007, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. R. Nutiu and Y. Li, “Structure-switching signaling aptamers: transducing molecular recognition into fluorescence signaling,” Chemistry, vol. 10, no. 8, pp. 1868–1876, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. P. C. Hoffman, A. M. Mauer, and E. E. Vokes, “Lung cancer,” Lancet, vol. 355, no. 9202, pp. 479–485, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. J. L. Mulshine and D. C. Sullivan, “Lung cancer screening,” New England Journal of Medicine, vol. 352, no. 26, pp. 2714–2720, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. J. E. Smith, C. D. Medley, Z. Tang, D. Shangguan, C. Lofton, and W. Tan, “Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells,” Analytical Chemistry, vol. 79, no. 8, pp. 3075–3082, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. X. Zhao, L. R. Hilliard, S. J. Mechery et al., “A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 42, pp. 15027–15032, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. X. Zhao, R. Tapec-Dytioco, and W. Tan, “Ultrasensitive DNA detection using highly fluorescent bioconjugated nanoparticles,” Journal of the American Chemical Society, vol. 125, no. 38, pp. 11474–11475, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. X. Zhao, R. P. Bagwe, and W. Tan, “Development of organic-dye-doped silica nanoparticles in a reverse microemulsion,” Advanced Materials, vol. 16, no. 2, pp. 173–176, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. J. K. Herr, J. E. Smith, C. D. Medley, D. Shangguan, and W. Tan, “Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells,” Analytical Chemistry, vol. 78, no. 9, pp. 2918–2924, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. H. W. Chen, C. D. Medley, K. Sefah et al., “Molecular recognition of small-cell lung cancer cells using aptamers,” ChemMedChem, vol. 3, no. 6, pp. 991–1001, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. D. J. Javier, N. Nitin, M. Levy, A. Ellington, and R. Richards-Kortum, “Aptamer-targeted gold nanoparticles as molecular-specific contrast agents for reflectance imaging,” Bioconjugate Chemistry, vol. 19, no. 6, pp. 1309–1312, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. C.-C. Huang, S.-H. Chiu, Y.-F. Huang, and H.-T. Chang, “Aptamer-functionalized gold nanoparticles for turn-on light switch detection of platelet-derived growth factor,” Analytical Chemistry, vol. 79, no. 13, pp. 4798–4804, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. O. C. Farokhzad, J. Cheng, B. A. Teply et al., “Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 16, pp. 6315–6320, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. O. C. Farokhzad, S. Jon, A. Khademhosseini, T.-N. T. Tran, D. A. LaVan, and R. Langer, “Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells,” Cancer Research, vol. 64, no. 21, pp. 7668–7672, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. O. C. Farokhzad, A. Khademhosseini, S. Jon et al., “Microfluidic system for studying the interaction of nanoparticles and microparticles with cells,” Analytical Chemistry, vol. 77, no. 17, pp. 5453–5459, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. S. Dhar, F. X. Gu, R. Langer, O. C. Farokhza, and S. J. Lippard, “Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 45, pp. 17356–17361, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. Y. Wu, K. Sefah, H. Liu, R. Wang, and W. Tan, “DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 1, pp. 5–10, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. C. Walsh, “Molecular mechanisms that confer antibacterial drug resistance,” Nature, vol. 406, no. 6797, pp. 775–781, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. D. Hanahan, G. Bergers, and E. Bergsland, “Less is, more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice,” Journal of Clinical Investigation, vol. 105, no. 8, pp. 1045–1047, 2000. View at Scopus
  68. H. Joensuu, K. Holli, M. Heikkinen et al., “Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial,” Journal of Clinical Oncology, vol. 16, no. 12, pp. 3720–3730, 1998. View at Scopus
  69. Y. Wang, S. Gao, W.-H. Ye, H. S. Yoon, and Y.-Y. Yang, “Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer,” Nature Materials, vol. 5, no. 10, pp. 791–796, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. Y. Wang, L.-S. Wang, S.-H. Goh, and Y.-Y. Yang, “Synthesis and characterizationo of cationic micelles self-assembled from a biodegradable copolymer for gene delivery,” Biomacromolecules, vol. 8, no. 3, pp. 1028–1037, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. N. Wiradharma, Y. W. Tong, and Y.-Y. Yang, “Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect,” Biomaterials, vol. 30, no. 17, pp. 3100–3109, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. L. Cerchia, P. H. Giangrande, J. O. McNamara, and V. de Franciscis, “Cell-specific aptamers for targeted therapies,” Methods in Molecular Biology, vol. 535, pp. 59–78, 2009.
  73. T. C. Chu, K. Y. Twu, A. D. Ellington, and M. Levy, “Aptamer mediated siRNA delivery,” Nucleic Acids Research, vol. 34, no. 10, article e73, 2006. View at Publisher · View at Google Scholar · View at PubMed
  74. J. O. McNamara II, E. R. Andrechek, Y. Wang et al., “Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras,” Nature Biotechnology, vol. 24, no. 8, pp. 1005–1015, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. E. Kim, Y. Jung, H. Choi et al., “Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex,” Biomaterials, vol. 31, no. 16, pp. 4592–4599, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. Y. Bae, S. Fukushima, A. Harada, and K. Kataoka, “Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change,” Angewandte Chemie. International Edition, vol. 42, no. 38, pp. 4640–4643, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. G. Helmlinger, A. Sckell, M. Dellian, N. S. Forbes, and R. K. Jain, “Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism,” Clinical Cancer Research, vol. 8, no. 4, pp. 1284–1291, 2002. View at Scopus
  78. Y. Matsumura and H. Maeda, “A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs,” Cancer Research, vol. 46, no. 12, part 1, pp. 6387–6392, 1986. View at Scopus
  79. K. Kataoka, G. S. Kwon, M. Yokoyama, T. Okano, and Y. Sakurai, “Block copolymer micelles as vehicles for drug delivery,” Journal of Controlled Release, vol. 24, no. 1–3, pp. 119–132, 1993. View at Publisher · View at Google Scholar · View at Scopus
  80. G. S. Kwon and T. Okano, “Polymeric micelles as new drug carriers,” Advanced Drug Delivery Reviews, vol. 21, no. 2, pp. 107–116, 1996. View at Publisher · View at Google Scholar · View at Scopus
  81. G. S. Kwon, M. Naito, M. Yokoyama, T. Okano, Y. Sakurai, and K. Kataoka, “Physical entrapment of adriamycin in AB block copolymer micelles,” Pharmaceutical Research, vol. 12, no. 2, pp. 192–195, 1995. View at Scopus
  82. H. S. Yoo, E. A. Lee, and T. G. Park, “Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages,” Journal of Controlled Release, vol. 82, no. 1, pp. 17–27, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. H. S. Yoo, K. H. Lee, J. E. Oh, and T. G. Park, “In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates,” Journal of Controlled Release, vol. 68, no. 3, pp. 419–431, 2000. View at Publisher · View at Google Scholar · View at Scopus
  84. T. M. Allen, “Liposomal drug formulations: rationale for development and what we can expect for the future,” Drugs, vol. 56, no. 5, pp. 747–756, 1998. View at Scopus
  85. D. Momekova, S. Rangelov, S. Yanev et al., “Long-circulating, pH-sensitive liposomes sterically stabilized by copolymers bearing short blocks of lipid-mimetic units,” European Journal of Pharmaceutical Sciences, vol. 32, no. 4-5, pp. 308–317, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. M. C. Woodle, “Sterically stabilized liposome therapeutics,” Advanced Drug Delivery Reviews, vol. 16, no. 2-3, pp. 249–265, 1995. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Zalipsky, “Chemistry of polyethylene glycol conjugates with biologically,” Advanced Drug Delivery Reviews, vol. 16, no. 2-3, pp. 157–182, 1995. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Gabizon and D. Papahadjopoulos, “Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 18, pp. 6949–6953, 1988. View at Scopus
  89. M. Hrubý, C. Koňák, and K. Ulbrich, “Polymeric micellar pH-sensitive drug delivery system for doxorubicin,” Journal of Controlled Release, vol. 103, no. 1, pp. 137–148, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. M.-S. Hong, S.-J. Lim, Y.-K. Oh, and C.-K. Kim, “pH-sensitive, serum-stable and long-circulating liposomes as a new drug delivery system,” Journal of Pharmacy and Pharmacology, vol. 54, no. 1, pp. 51–58, 2002. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Simões, J. N. Moreira, C. Fonseca, N. Düzgüneş, and M. C. P. de Lima, “On the formulation of pH-sensitive liposomes with long circulation times,” Advanced Drug Delivery Reviews, vol. 56, no. 7, pp. 947–965, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. Y. Bae, W.-D. Jang, N. Nishiyama, S. Fukushima, and K. Kataoka, “Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery,” Molecular BioSystems, vol. 1, no. 3, pp. 242–250, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. Y. Bae and K. Kataoka, “Significant enhancement of antitumor activity and bioavailability of intracellular pH-sensitive polymeric micelles by folate conjugation,” Journal of Controlled Release, vol. 116, no. 2, pp. e49–e50, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. Y. Bae, N. Nishiyama, S. Fukushima, H. Koyama, M. Yasuhiro, and K. Kataoka, “Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy,” Bioconjugate Chemistry, vol. 16, no. 1, pp. 122–130, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  95. Y. Bae, N. Nishiyama, and K. Kataoka, “In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments,” Bioconjugate Chemistry, vol. 18, no. 4, pp. 1131–1139, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. G. Shi, W. Guo, S. M. Stephenson, and R. J. Lee, “Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations,” Journal of Controlled Release, vol. 80, no. 1–3, pp. 309–319, 2002. View at Publisher · View at Google Scholar · View at Scopus
  97. J. J. Sudimack, W. Guo, W. Tjarks, and R. J. Lee, “A novel pH-sensitive liposome formulation containing oleyl alcohol,” Biochimica et Biophysica Acta, vol. 1564, no. 1, pp. 31–37, 2002. View at Publisher · View at Google Scholar · View at Scopus
  98. T. Ishida, M. J. Kirchmeier, E. H. Moase, S. Zalipsky, and T. M. Allen, “Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells,” Biochimica et Biophysica Acta, vol. 1515, no. 2, pp. 144–158, 2001. View at Publisher · View at Google Scholar · View at Scopus
  99. Y. Li and G. S. Kwon, “Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L- aspartamide). Part I: effects of the level of methotrexate conjugation on the stability of micelles and on drug release,” Pharmaceutical Research, vol. 17, no. 5, pp. 607–611, 2000. View at Publisher · View at Google Scholar · View at Scopus
  100. M. G. Rimoli, L. Avallone, P. de Caprariis, A. Galeone, F. Forni, and M. A. Vandelli, “Synthesis and characterisation of poly(D,L-lactic acid)-idoxuridine conjugate,” Journal of Controlled Release, vol. 58, no. 1, pp. 61–68, 1999. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Zacchigna, G. Di Luca, F. Cateni, S. Zorzet, and V. Maurich, “Improvement of physicochemical and biopharmaceutical properties of theophylline by poly(ethylene glycol) conjugates,” Farmaco, vol. 58, no. 12, pp. 1307–1312, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. K. Hoste, K. de Winne, and E. Schacht, “Polymeric prodrugs,” International Journal of Pharmaceutics, vol. 277, no. 1-2, pp. 119–131, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  103. E. Mastrobattista, G. A. Koning, L. van Bloois, A. C. S. Filipe, W. Jiskoot, and G. Storm, “Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins,” Journal of Biological Chemistry, vol. 277, no. 30, pp. 27135–27143, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  104. C. J. Provoda, E. M. Stier, and K.-D. Lee, “Tumor cell killing enabled by listeriolysin O-liposome-mediated delivery of the protein toxin gelonin,” Journal of Biological Chemistry, vol. 278, no. 37, pp. 35102–35108, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  105. R. Ishiguro, M. Matsumoto, and S. Takahashi, “Interaction of fusogenic synthetic peptide with phospholipid bilayers: orientation of the peptide α-helix and binding isotherm,” Biochemistry, vol. 35, no. 15, pp. 4976–4983, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  106. S. Nir, F. Nicol, and F. C. Szoka Jr., “Surface aggregation and membrane penetration by peptides: relation to pore formation and fusion,” Molecular Membrane Biology, vol. 16, no. 1, pp. 95–101, 1999. View at Scopus
  107. J.-C. Leroux, E. Roux, D. Le Garrec, K. Hong, and D. C. Drummond, “N-isopropylacrylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles,” Journal of Controlled Release, vol. 72, no. 1–3, pp. 71–84, 2001. View at Publisher · View at Google Scholar · View at Scopus
  108. T. Mizoue, T. Horibe, K. Maruyama et al., “Targetability and intracellular delivery of anti-BCG antibody-modified, pH-sensitive fusogenic immunoliposomes to tumor cells,” International Journal of Pharmaceutics, vol. 237, no. 1-2, pp. 129–137, 2002. View at Publisher · View at Google Scholar · View at Scopus
  109. V. P. Torchilin, F. Zhou, and L. Huang, “pH-Sensitive liposomes,” Journal of Liposome Research, vol. 3, no. 2, pp. 201–255, 1993. View at Scopus
  110. D. D. Lasic, “Novel applications of liposomes,” Trends in Biotechnology, vol. 16, no. 7, pp. 307–321, 1998. View at Publisher · View at Google Scholar · View at Scopus
  111. C.-J. Chu, J. Dijkstra, M.-Z. Lai, K. Hong, and F. C. Szoka, “Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture,” Pharmaceutical Research, vol. 7, no. 8, pp. 824–834, 1990. View at Scopus
  112. V. A. Slepushkin, S. Simões, P. Dazin et al., “Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo,” Journal of Biological Chemistry, vol. 272, no. 4, pp. 2382–2388, 1997. View at Publisher · View at Google Scholar · View at Scopus
  113. M. B. Yatvin, J. N. Weinstein, W. H. Dennis, and R. Blumenthal, “Design of liposomes for enhanced local release of drugs by hyperthermia,” Science, vol. 202, no. 4374, pp. 1290–1293, 1978. View at Scopus
  114. J. van der Zee, D. González González, G. C. Van Rhoon, J. D. P. Van Dijk, W. L. J. Van Putten, and A. A. M. Hart, “Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial,” Lancet, vol. 355, no. 9210, pp. 1119–1125, 2000. View at Scopus
  115. R. D. Issels, L. H. Lindner, P. Wust, et al., “Regional hyperthermia (RHT) improves response and survival when combined with systemic chemotherapy in the management of locally advanced, high grade soft tissue sarcomas (STS) of the extremities, the body wall and the abdomen: a phase III randomised prospective trial (EORTC-ESHO intergroup trial),” in Proceedings of the 43rd Annual Meeting of ASCO, Chicago, Ill, USA, 2007.
  116. G. Crile Jr., “Selective destruction of cancers after exposure to heat,” Annals of surgery, vol. 156, pp. 404–407, 1962. View at Scopus
  117. G. Kong, R. D. Braun, and M. W. Dewhirst, “Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature,” Cancer Research, vol. 61, no. 7, pp. 3027–3032, 2001. View at Scopus
  118. M. H. Gaber, N. Z. Wu, K. Hong, S. K. Huang, M. W. Dewhirst, and D. Papahadjopoulos, “Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks,” International Journal of Radiation Oncology Biology Physics, vol. 36, no. 5, pp. 1177–1187, 1996. View at Publisher · View at Google Scholar · View at Scopus
  119. G. Kong, R. D. Braun, and M. W. Dewhirst, “Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size,” Cancer Research, vol. 60, no. 16, pp. 4440–4445, 2000. View at Scopus
  120. L. Huang, K. Ozato, and R. E. Pagano, “Interactions of phospholipid vesicles with murine lymphocytes. I. Vesicle-cell adsorption and fusion as alternate pathways of uptake,” Membrane Biochemistry, vol. 1, no. 1-2, pp. 1–25, 1978. View at Scopus
  121. L. F. Fajardo and S. D. Prionas, “Endothelial cells and hyperthermia,” International Journal of Hyperthermia, vol. 10, no. 3, pp. 347–353, 1994. View at Scopus
  122. D. Papahadjopoulos, K. Jacobson, S. Nir, and T. Isac, “Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol,” Biochimica et Biophysica Acta, vol. 311, no. 3, pp. 330–348, 1973. View at Scopus
  123. T. Y. Tsong, “Kinetics of the crystalline liquid crystalline phase transition of dimyristoyl L α lecithin bilayers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 71, no. 7, pp. 2684–2688, 1974. View at Scopus
  124. T. M. Allen, C. Hansen, F. Martin, C. Redemann, and A. F. Yau-Young, “Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo,” Biochimica et Biophysica Acta, vol. 1066, no. 1, pp. 29–36, 1991. View at Publisher · View at Google Scholar · View at Scopus
  125. H. Yoshioka, “Surface modification of haemoglobin-containing liposomes with polyethylene glycol prevents liposome aggregation in blood plasma,” Biomaterials, vol. 12, no. 9, pp. 861–864, 1991. View at Publisher · View at Google Scholar · View at Scopus
  126. A. R. Nicholas, M. J. Scott, N. I. Kennedy, and M. N. Jones, “Effect of grafted polyethylene glycol (PEG) on the size, encapsulation efficiency and permeability of vesicles,” Biochimica et Biophysica Acta, vol. 1463, no. 1, pp. 167–178, 2000. View at Publisher · View at Google Scholar · View at Scopus
  127. A. K. Kenworthy, K. Hristova, D. Needham, and T. J. McIntosh, “Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol),” Biophysical Journal, vol. 68, no. 5, pp. 1921–1936, 1995. View at Scopus
  128. S. Mabrey and J. M. Sturtevant, “Investigation of phase transitions of lipids and lipid mixtures by high sensitivity differential scanning calorimetry,” Proceedings of the National Academy of Sciences of the United States of America, vol. 73, no. 11, pp. 3862–3866, 1976. View at Scopus
  129. M. Hossann, M. Wiggenhorn, A. Schwerdt et al., “In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes,” Biochimica et Biophysica Acta, vol. 1768, no. 10, pp. 2491–2499, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  130. D. Needham, G. Anyarambhatla, G. Kong, and M. W. Dewhirst, “A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model,” Cancer Research, vol. 60, no. 5, pp. 1197–1201, 2000.
  131. L. H. Lindner, M. E. Eichhorn, H. Eibl et al., “Novel temperature-sensitive liposomes with prolonged circulation time,” Clinical Cancer Research, vol. 10, no. 6, pp. 2168–2178, 2004. View at Publisher · View at Google Scholar
  132. G. Kong, G. Anyarambhatla, W. P. Petros et al., “Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release,” Cancer Research, vol. 60, no. 24, pp. 6950–6957, 2000.
  133. M. L. Hauck, S. M. La Rue, W. P. Petros et al., “Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors,” Clinical Cancer Research, vol. 12, no. 13, pp. 4004–4010, 2006. View at Publisher · View at Google Scholar · View at PubMed
  134. O. Soga, C. F. van Nostrum, A. Ramzi et al., “Physicochemical characterization of degradable thermosensitive polymeric micelles,” Langmuir, vol. 20, no. 21, pp. 9388–9395, 2004. View at Publisher · View at Google Scholar · View at PubMed
  135. D. Neradovic, C. F. van Nostrum, and W. E. Hennink, “Thermoresponsive polymeric micelles with controlled instability based on hydrolytically sensitive N-isopropylacrylamide copolymers,” Macromolecules, vol. 34, no. 22, pp. 7589–7591, 2001. View at Publisher · View at Google Scholar
  136. O. Soga, C. F. van Nostrum, and W. E. Hennink, “Poly(N-(2-hydroxypropyl) methacrylamide mono/di lactate): a new class of biodegradable polymers with tuneable thermosensitivity,” Biomacromolecules, vol. 5, no. 3, pp. 818–821, 2004. View at Publisher · View at Google Scholar · View at PubMed
  137. C. J. F. Rijcken, T. F. J. Veldhuis, A. Ramzi, J. D. Meeldijk, C. van Nostrum, and W. E. Hennink, “Novel fast degradable thermosensitive polymeric micelles based on PEG-block-poly(N-(2-hydroxyethyl)methacrylamide-oligolactates),” Biomacromolecules, vol. 6, no. 4, pp. 2343–2351, 2005. View at Publisher · View at Google Scholar · View at PubMed
  138. G. Molineux, “Pegylation: engineering improved pharmaceuticals for enhanced therapy,” Cancer Treatment Reviews, vol. 28, supplement A, pp. 13–16, 2002.
  139. O. Soga, C. F. van Nostrum, M. Fens et al., “Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery,” Journal of Controlled Release, vol. 103, no. 2, pp. 341–353, 2005. View at Publisher · View at Google Scholar · View at PubMed
  140. O. Soga, In vivo efficacy of paclitaxel-loaded thermosensitive biodegradable polymeric micelles, M.S. thesis, Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands, 2006.
  141. C. J. Rijcken, C. J. Snel, R. M. Schiffelers, C. F. van Nostrum, and W. E. Hennink, “Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies,” Biomaterials, vol. 28, no. 36, pp. 5581–5593, 2007. View at Publisher · View at Google Scholar · View at PubMed